Tuesday, 1 August 2017

ENT Devices Market by Product - Global Industry Analysis and Forecast to 2025




Ear, nose, and throat (ENT) disorders are the most common reasons for visits to a primary care physician. Most patients with ENT disorders visit the doctor early in the disease process as associated symptoms and signs are readily visible. The physical appearance of the tongue, teeth, gums, and palate indicates different physiological states. These indications can be used to detect and diagnose the particular disorder. Some of the common ENT disorders are chronic, acute and recurrent tonsillitis, recurrent and acute otitis media (OM), and recurrent and allergic rhinitis along with chronic rhino sinusitis (CRS). Common cold is the most frequent upper respiratory tract infection (URI). Nearly half of the cases of cold affecting children can be attributed to a variety of up to 200 distinct viruses which are seasonally active (Source: Journal of Biomedical Therapy 2010 Vol. 4, No. 2). For instance, rhinoviruses are active in the early fall, summer, and spring. Disorders related to the ear such as hearing loss constitute a considerable share of ENT disorders. According to the National Institute of Deafness and Other Communication Disorders (NIDCD), 2 to 3 among every 1,000 children in the U.S. are born with detectable level of hearing impairment in one or both ears. Hearing aids and hearing implants are used to treat the hearing impaired patients. While hearing aids amplify the incoming sound, implants transform sound into electrical signals that stimulate the patient’s auditory nerve.
Request for an in-depth table of contents for this report @ https://www.crystalmarketresearch.com/request-toc/upcoming/HC0655
Some of the key factors driving the ENT devices market are rising incidence of ENT related infections and traumas, increased prevalence of geriatric population around the world, and growing awareness about ENT disorders and their prevention and cure among the target population. According to the data revealed by the (NIDCD) in 2016, the highest amounts of hearing loss disorders exist in the age group between 60 and 69. As per a study conducted by Action on Hearing Loss, in 2015, over 11 million people in UK were living with some form of hearing loss, which amounts to one in every 6 persons in the UK. According to the data revealed in 2016 by health direct, an information service supported by Government of Australia, adults usually encounter 2 to 4 colds every year whereas, children usually get affected by cold 5 to 10 times in a year as they are less immune to cold causing viruses. Such high prevalence of common cold in children and adults will favorably contribute to the growth of ENT devices market over the forecast period. However, factors such as high cost and unfavorable reimbursement policies for hearing aids are likely to hinder the growth of ENT devices market.
Technological advancements in ENT diagnostic and surgical devices will offer lucrative growth opportunities for the manufacturers. Latest developments in minimally invasive Trans-Oral Robotic Surgeries (TORS) are highly effective as recovery time for patients undergoing such surgeries is considerably reduced. In these surgeries, surgeons use computer enhanced, sophisticated systems to remove oral cancers assisted by an enhanced view of the existing cancer and the surrounding tissue.
Some of the key players in the ENT devices market are Medtronic plc. Stryker Corporation, Olympus Corporation, KARL STORZ GmbH & Co. KG, Smith & Nephew plc., Sonova Holdings AG, Acclarent, Inc., William Demant Holdings A/S, and Cochlear Limited. Development of technologically advanced ENT devices is the key strategy adopted by these players. For instance, in September 2016, Med-El obtained FDA approval for its SYNCHRONY EAS (Electrical Acoustic Stimulation) hearing implant system. This system is a combination of two technologies viz. the Synchrony cochlear implant technology, which is used to stimulate the auditory nerve in high frequency hearing loss, and the SONNET EAS audio processor, which has built-in acoustic amplification used for low frequency hearing loss.
About Crystal Market Research
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.
Contact:
Judy
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Connect with us:  LinkedIn | Twitter | Facebook

Orthopedic Soft Tissue Repair Market by Procedure and Injury Location: Global Industry Analysis and Forecast to 2025




Soft tissue damage occurs due to direct or indirect trauma to muscles, joint capsules and ligaments. Direct trauma or macro-trauma refers to an injury due to sudden overload on ligaments or joint capsules. Indirect trauma results from repeated sub-maximal loading leading to clinical symptoms and signs. Whether injury is caused due to direct or indirect trauma, the ultimate result is tissue dysfunction characterized by inflammation, pain, and altered internal tissue stress. Of all the tissues involved, the least elastic tissue is a tendon.
Examination of an injury in soft tissues such as muscles is done through initial palpation with minimal compression or force in case of acute injuries. If pain has not been provoked at the site, then higher loads or firmer compression is used. Some of the examination techniques used to examine soft tissue damage are inspection, palpation, and peripheral nerve tests, deep tendon reflexes, strength and motor control tests, and gait analysis.
Tissue repair refers to the replacement of a destroyed tissue by a living tissue. It essentially comprises of two components viz. regeneration and repair. In regeneration, the damaged tissue is replaced through the proliferation of surrounding specialized cells which are undamaged. In repair, the damaged tissue is replaced by a granulation tissue that matures to form a scar tissue. The repair process generally comprises of the bleeding, inflammation, proliferation, and remodeling phases. The bleeding phase is a relatively shorter phase and occurs following a trauma or injury. The inflammatory phase increases in magnitude for up to 1 to 3 days before resolving gradually over the next few weeks. The proliferation phase involves generation of repair material such as the scar material. The remodeling phase is important in context of therapy and rehabilitation. In the final outcome, the damaged tissue is repaired with a scar tissue which enables quality recovery from the injury.
Request for an in-depth table of contents for this report @ https://www.crystalmarketresearch.com/request-toc/upcoming/HC0645
The key driving factors for the global orthopedic soft tissue repair market are the rising incidence of sports injuries, increasing geriatric population and obesity in aging people. Sports injuries are a major cause for muscle damage. Usually sports and related physical activities result in damage of the anterior cruciate ligament (ACL). According to 2016 national health statistics report by the U.S. Department of Health and Human Services, on an average, American people aged five years and above sustained around 8.6 million sports and recreation related injuries every year between 2011 and 2014. Geriatric population is more vulnerable to damage of the orthopedic soft tissues as aging may result into changes in skeletal system leading to weak ligaments, arthritis, and ACL tear. Obesity in aging people can increase the possibility of degenerative bone disorders such as osteoporosis and osteoarthritis. The high cost of orthopedic soft tissue repair surgeries and availability of non-surgical alternatives such as PRP (Platelet Rich Plasma) injection can decrease the demand for surgical orthopedic soft tissue repair procedures in the coming years.
With high healthcare expenditure in developed countries, advanced orthopedic soft tissue repair procedures are being designed and developed to facilitate enhanced repair and replacement of damaged tissues. With a rising acceptance of sports on a professional level in developing countries, incidence of sports injuries will prevail over the next few years. Also, due to the presence of high unmet medical needs in emerging nations, acceptance of advanced and affordable orthopedic soft tissue repair procedures will witness a rise in coming years. Increased life expectancy due to advancements in healthcare will ensure prevalence of geriatric population across the globe, which will further contribute to the growth of global orthopedic soft tissue repair market.
Some of the key players in this market are Stryker Corporation, Arthrex, Inc., DePuy Synthes, Inc., Zimmer Biomet, CONMED Corporation, ArthroCare Corporation, and Smith & Nephew plc. These companies focus on strategic acquisitions and mergers in order to gain competitive advantage. For instance, in July 2015, Integra Lifesciences acquired TEI Biosciences Inc. and TEI Medical Inc. to broaden Integra’s portfolio for regenerative wound care and tissue repair. This acquisition offers a regenerative technology platform to the surgeons for indications in wound repair and soft tissue reconstruction.
About Crystal Market Research
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.
Contact:
Judy
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Connect with us:  LinkedIn | Twitter | Facebook

Insulin Patch Pump Market Size Is Expected To Witness Significant Growth By 2025: Crystal Market Research




A research study titled, “Insulin Patch Pump Market by Type and Application - Global Industry Analysis and Forecast to 2025” published by Crystal Market Research, states that Insulin Patch Pump Market is expected to witness significant growth by 2025.
Diabetes is a chronic disease which occurs either when the pancreas fails to develop sufficient insulin or when the human body is unable to effectively use the insulin. Symptoms associated with diabetes are frequent urination, blurred vision, increased thirst, rapid weight loss, numbness or tingling sensation in hands or feet and increased hunger. Factors which escalate the risk of diabetes are family history, ethnicity, physical inactivity, unhealthy diet, and smoking. Diabetes can damage the heart, eyes, blood vessels, kidneys, and nerves which may lead to disability and premature death. There are three types of diabetes, namely, type 1, type 2, and gestational diabetes. Type 1 diabetes can cause because of complex interaction between genes and environmental factors. The most common risk factors for type 2 diabetes are overweight and obesity. Type 2 diabetes is the most common type of diabetes worldwide. It is typically countered with changes in lifestyle activities such as improved diet and increased physical activity. While insulin is rarely prescribed as the initial drug for a type 2 diabetes patient, many of them may ultimately need it to control blood glucose levels. Insulin patch pumps may work very well for numerous patients suffering from type 2 diabetes.
Browse full research report with TOC on “Insulin Patch Pump Market by Type and Application - Global Industry Analysis and Forecast to 2025” at: https://www.crystalmarketresearch.com/report/insulin-patch-pump-market
The development of patch pump technology has given an opportunity for improving the quality of life of a broad demography of diabetes patients. The insulin patch pump technology offers enhanced therapeutic benefits over traditional multiple daily injection therapy. Currently available patch pumps are about the size of a computer mouse which can be directly attached to the body without any tubing. For the infusion of insulin, a small catheter is subcutaneously inserted from the underside of the patch pump. The three main components of an insulin patch pump are an insulin reservoir, a cannula and a pumping mechanism. Unlike traditional pumps, these parts are contained in a single case without any tubing. The device is directly worn on the body using an adhesive patch. The activation of the patch is programmed from a remote device and the cannula is inserted automatically.
Basal insulin comprises of a majority of a person’s daily insulin requirement. It offsets the liver’s glucose secretion into the bloodstream. Every few minutes, the pancreas, in response to the liver’s secretion of glucose, secretes a small amount of insulin in the bloodstream which is known as basal insulin. Before a person develops diabetes, pancreas regularly produce insulin proportionate to the amount of glucose present in the bloodstream. When there is a large amount of blood glucose in the body, such as after meals, the pancreas secret larger amounts of insulin known as bolus insulin. Using patch pumps, the rate of insulin delivery can be adjusted in response to the liver’s pattern of glucose secretion.
The major factor responsible for the growth of insulin pump market is increasing prevalence of diabetes. According to IDF, in 2015, diabetes affected 415 million people worldwide. This number is expected to reach up to 642 million by 2040.By 2040, 1 in 10 adults will have diabetes. With such rising incidence of diabetes around the world, the demand for insulin patch pumps is expected to increase favorably during the forecast period. As diabetic patients are becoming increasingly aware about the technologically advanced alternatives to control and manage diabetes, the insulin patch pump market will experience innovations in the near future leading to development of new-age insulin patch pump systems with enhanced insulin delivering capabilities.
Request a sample copy of Insulin Patch Pump Market Research Report @ https://www.crystalmarketresearch.com/report-sample/HC07183
Some of the major players operating in the insulin patch pump marketare, Insulet Corporation, Debiotech S.A.,CeQur SA, Unilife Corporation, Valeritas Holdings, Inc., Cellnovo Limited., EOFLOW CO., LTD., Becton, Dickinson and Company.
Key Findings of the Research Study:
·         Rising incidence of diabetes around the world is expected to primarily drive the growth of insulin patch pump market during the forecast period.
·         Insulin patch pump provides an efficient alternative to traditional multiple injection based insulin delivery systems.
·         Development of insulin patch pumps by numerous players under pipeline will favorably contribute to the market growth over coming few years.
·         North America holds the major share of the insulin patch pump market due to the commercial availability and rapid adoption of insulin patch pumps in the region.
Insulin Patch Pump Market Segmentation:
By Type of Insulin:
  • Basal Insulin
  • Bolus Insulin
  • Basal-Bolus Insulin
By End User:
  • Hospitals
  • Private clinics
  • Online pharmacies
  • Retail pharmacies
By Region:
  • North America
o    U.S
o    Canada
o    Mexico
  • Europe
o    Germany
o    France
o    UK
o    Italy
o    Spain
o    Rest of Europe
  • Asia-Pacific
o    Japan
o    China
o    Australia
o    India
o    South Korea
o    Rest of Asia Pacific
  • Rest of the World
o    Brazil
o    South Africa
o    Saudi Arabia
o    United Arab Emirates
o    Others
Related Reports:
Diabetes Devices and Drugs Market by Devices and Therapy - Global Industry Analysis and Forecast to 2025: https://www.crystalmarketresearch.com/report/diabetes-devices-and-drugs-market
Smart Insulin or Glucose Responsive Insulin Market by Type, Disease, and Delivery Device - Global Industry Analysis and Forecast to 2025: https://www.crystalmarketresearch.com/report/smart-insulin-or-glucose-responsive-insulin-market
Artificial Pancreas Device System Market by Device Type - Global Industry Analysis and Forecast to 2025: https://www.crystalmarketresearch.com/report/artificial-pancreas-device-system-market
About Crystal Market Research
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.
Contact:
Judy
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Connect with us:  LinkedIn | Twitter | Facebook